SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

HC Wainwright Maintains Axogen Buy Rating, Raises Target to $56

HC Wainwright & Co. raised its price target from $53 to $56 while maintaining its Buy rating. The new target implies 13.7% upside from Axogen’s Oct. 28 close of $49.25.

AXGN

Related stories